CN116375702A - 1,2,3, 4-tetrahydro-beta-carboline compound containing alkyl or aryl, composition, preparation method and application - Google Patents
1,2,3, 4-tetrahydro-beta-carboline compound containing alkyl or aryl, composition, preparation method and application Download PDFInfo
- Publication number
- CN116375702A CN116375702A CN202310256181.3A CN202310256181A CN116375702A CN 116375702 A CN116375702 A CN 116375702A CN 202310256181 A CN202310256181 A CN 202310256181A CN 116375702 A CN116375702 A CN 116375702A
- Authority
- CN
- China
- Prior art keywords
- optionally substituted
- unsubstituted
- aryl
- alkyl
- tryptamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G7/00—Botany in general
- A01G7/06—Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Ecology (AREA)
- Forests & Forestry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及药物化学技术领域,特别涉及一种含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物、组合、制备方法和应用。The present invention relates to the technical field of pharmaceutical chemistry, and in particular to a 1,2,3,4-tetrahydro-β-carboline compound containing an alkyl group or an aromatic group, a combination, a preparation method and an application thereof.
背景技术Background Art
植物细菌性病害是影响全球农业生产的主要因素之一,严重影响农产品的产量和质量,不但造成极大的经济损失,还威胁着人类的健康。如水稻白叶枯病、柑橘溃疡病、猕猴桃溃疡病、烟草青枯病等,每年都会不同程度地爆发,给农民造成巨大的经济损失。长期使用传统杀菌剂,如噻菌铜、叶枯唑、硫酸链霉素等,不仅增加了植物病原菌的抗药性,而且对生态环境和植物的安全都造成了有害影响。Plant bacterial diseases are one of the main factors affecting global agricultural production, seriously affecting the yield and quality of agricultural products, not only causing great economic losses, but also threatening human health. For example, rice bacterial blight, citrus canker, kiwi canker, tobacco bacterial wilt, etc., break out to varying degrees every year, causing huge economic losses to farmers. The long-term use of traditional fungicides, such as thiophanate-methyl, chlorothalonil, streptomycin sulfate, etc., not only increases the drug resistance of plant pathogens, but also has a harmful impact on the ecological environment and plant safety.
植物真菌病害是由植物病原真菌引起的病害,约占植物病害的70~80%。一种作物上可发现几种甚至几十种真菌病害,导致农作物坏死、腐烂、蔫焉,还会出现特定的病症,即病原物在病部组织上的特殊表现,如黑色小颗粒、轮纹状霉层、絮状物等。目前,常用的杀菌剂有含硫杀菌剂(如甲基硫菌灵)、含铜杀菌剂(如波尔多液)、有机杀菌剂(如苦楝油),这些杀菌剂或效果不好,或选择性不高。Plant fungal diseases are caused by plant pathogenic fungi, accounting for about 70-80% of plant diseases. Several or even dozens of fungal diseases can be found on a crop, causing necrosis, rot, and wilt of the crop. Specific symptoms may also occur, that is, the special manifestations of pathogens on the diseased tissue, such as small black particles, ring-shaped mold layers, flocculent matter, etc. At present, commonly used fungicides include sulfur-containing fungicides (such as methyl thiophanate), copper-containing fungicides (such as Bordeaux mixture), and organic fungicides (such as neem oil). These fungicides are either ineffective or not highly selective.
因此,有必要开发一种抗细菌病害同时又抗真菌病害的化合物,为新农药的研发和创制提供科学基础。Therefore, it is necessary to develop a compound that is resistant to both bacterial and fungal diseases to provide a scientific basis for the research and development and creation of new pesticides.
发明内容Summary of the invention
有鉴于此,本发明目的在于提供一种含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物、含该化合物的组合物及其制备方法和应用,本发明提供的化合物对植物病原细菌具有良好的抑制作用,同时对植物病原真菌具有优异的防治效果。In view of this, the object of the present invention is to provide a 1,2,3,4-tetrahydro-β-carboline compound containing an alkyl or aromatic group, a composition containing the compound, and a preparation method and application thereof. The compound provided by the present invention has a good inhibitory effect on plant pathogenic bacteria and an excellent control effect on plant pathogenic fungi.
为了实现上述目的,本发明提供以下技术方案:一种含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物,其结构式如下所示:In order to achieve the above object, the present invention provides the following technical solution: a 1,2,3,4-tetrahydro-β-carboline compound containing an alkyl group or an aromatic group, the structural formula of which is shown below:
式中,R1和R2各自独立的选自氢、任意取代或未取代的烷基、任意取代或未取代的烯基、任意取代或未取代的环烷基、任意取代或未取代的芳基、任意取代或未取代的杂芳基中的一个或多个、任意取代或未取代的苄基、任意取代或未取代的α-甲基-苄基;In the formula, R1 and R2 are each independently selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl, optionally substituted or unsubstituted benzyl, and optionally substituted or unsubstituted α-methyl-benzyl;
或R1和R2相连构成任意取代的4-10元环或含杂原子的环,所述杂原子为N、O和S中的至少一个;or R1 and R2 are linked to form an optionally substituted 4-10 membered ring or a ring containing a heteroatom, wherein the heteroatom is at least one of N, O and S;
R3选自氢、任意取代或未取代的烷基、任意取代或未取代的烯基、任意取代或未取代的环烷基、任意取代或未取代的芳基、任意取代或未取代的杂芳基中的一个或多个、任意取代或未取代的苄基、任意取代或未取代的α-甲基-苄基;R3 is selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl, optionally substituted or unsubstituted benzyl, optionally substituted or unsubstituted α-methyl-benzyl;
优选的,所述R1和R2各自独立的选自氢、任意取代或未取代的C1-8烷基、任意取代或未取代的C2-6烯基、任意取代或未取代的C5-10环烷基、任意取代或未取代的C5-10芳基、任意取代或未取代的C5-10杂芳基、任意取代或未取代的苄基;Preferably, R1 and R2 are each independently selected from hydrogen, optionally substituted or unsubstituted C1-8 alkyl, optionally substituted or unsubstituted C2-6 alkenyl, optionally substituted or unsubstituted C5-10 cycloalkyl, optionally substituted or unsubstituted C5-10 aryl, optionally substituted or unsubstituted C5-10 heteroaryl, and optionally substituted or unsubstituted benzyl;
或R1和R2相连构成任意取代的5-10元环或含杂原子的环,所述杂原子为N、O和S中的至少一个;or R1 and R2 are linked to form an optionally substituted 5-10 membered ring or a ring containing a heteroatom, wherein the heteroatom is at least one of N, O and S;
R3选自氢、任意取代或未取代的C1-8烷基、任意取代或未取代的C2-6烯基、任意取代或未取代的C5-10环烷基、任意取代或未取代的C5-10芳基、任意取代或未取代的C5-10杂芳基、任意取代或未取代的苄基;R3 is selected from hydrogen, optionally substituted or unsubstituted C1-8 alkyl, optionally substituted or unsubstituted C2-6 alkenyl, optionally substituted or unsubstituted C5-10 cycloalkyl, optionally substituted or unsubstituted C5-10 aryl, optionally substituted or unsubstituted C5-10 heteroaryl, optionally substituted or unsubstituted benzyl;
优选的,所述R1、R2和R3各自独立的选氢、氘、甲基、乙基、正丙基、异丙基、苯基、正丁基、异丁基、仲丁基、叔丁基、正戊基、异戊基、新戊基、己基、庚基、辛基、1,1-二甲基、1,5-二甲基己基、1,1-二乙醇基、丙烯基、烯丙基、甲氧基、乙氧基、丙氧基、丁氧基、苯基、4-硝基苯基、4-乙氧基苯基、4-氨基苯基、2,4-二氟苯基、2-氯-4-氟苯基、2-甲基-4氟苯基、2,5-二氯苯基、2,4-二氯苯基、2-氯-4溴苯基、2-甲基-4氯苯基、4-甲基-3-氯苯基、苄基、2-氟苄基、4-氟苄基、4-三氟甲基苄基、2-氯苄基、3-氯苄基、4-氯苄基、4-甲基苄基、4-甲氧基苄基、苯乙基、环丙基、环戊基、呋喃甲基、噻吩甲基,α-甲基苄基、氟-α-甲基苄基、甲氧基-α-甲基苄基;Preferably, R1, R2 and R3 are each independently selected from hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, phenyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, 1,1-dimethyl, 1,5-dimethylhexyl, 1,1-diethanol, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, phenyl, 4-nitrophenyl, 4-ethoxyphenyl, 4-aminophenyl, 2,4-difluorophenyl, 2-chloro-4-nitro ... -fluorophenyl, 2-methyl-4-fluorophenyl, 2,5-dichlorophenyl, 2,4-dichlorophenyl, 2-chloro-4-bromophenyl, 2-methyl-4-chlorophenyl, 4-methyl-3-chlorophenyl, benzyl, 2-fluorobenzyl, 4-fluorobenzyl, 4-trifluoromethylbenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 4-methylbenzyl, 4-methoxybenzyl, phenethyl, cyclopropyl, cyclopentyl, furanyl, thephenylmethyl, α-methylbenzyl, fluoro-α-methylbenzyl, methoxy-α-methylbenzyl;
本发明还提供了所述含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物的制备方法,以色胺或色胺衍生物为起始原料,以三氟乙酸为催化剂,与酮或醛在溶剂中60℃加热搅拌反应6h~8h。The present invention also provides a method for preparing the alkyl or aromatic 1,2,3,4-tetrahydro-β-carboline compounds, which uses tryptamine or a tryptamine derivative as a starting material, trifluoroacetic acid as a catalyst, and reacts with ketone or aldehyde in a solvent at 60°C under stirring for 6 to 8 hours.
优选的,所述酮与色胺或色胺衍生物的摩尔比为1.2:1;所述醛与色胺或色胺衍生物的摩尔比为1.2:1。Preferably, the molar ratio of the ketone to tryptamine or a tryptamine derivative is 1.2:1; the molar ratio of the aldehyde to tryptamine or a tryptamine derivative is 1.2:1.
优选的,所述溶剂为二氯甲烷。Preferably, the solvent is dichloromethane.
本发明还提供了含有所述化合物的组合物。The present invention also provides a composition containing the compound.
优选的,所述组合物的剂型为乳油、可湿性粉剂、颗粒剂、水剂、悬浮剂、超低容量喷雾剂、可溶性粉剂、微胶囊剂、烟剂、水乳剂或水分散性粒剂。Preferably, the composition is in the form of emulsifiable concentrate, wettable powder, granules, aqueous solution, suspension, ultra-low volume spray, soluble powder, microcapsule, smoke concentrate, aqueous emulsion or water-dispersible granules.
本发明还提供了所述化合物或所述组合物在防治农业病虫害中的应用;所述农业病虫害为植物细菌性病害或植物真菌性病害。The present invention also provides the use of the compound or the composition in preventing and controlling agricultural pests and diseases; the agricultural pests and diseases are plant bacterial diseases or plant fungal diseases.
本发明还提供了一种防治农业病虫害的方法,将所述化合物或组合物作用于有害物或其生活的环境,或直接将组合物与植物接触。The present invention also provides a method for preventing and controlling agricultural pests and diseases, wherein the compound or composition acts on the harmful substance or the environment in which it lives, or the composition is directly contacted with the plant.
有益技术效果:Beneficial technical effects:
本发明以色胺或色胺类衍生物为起始原料,以不同结构的醛或酮作为连接链,将一系列烷基或氨基引入到此体系中,合成一系列1,2,3,4-四氢-β-咔啉类化合物,该类化合物对植物病原细菌如水稻白叶枯病菌、柑橘溃疡病菌、猕猴桃溃疡病菌等具有优异的抑制效果;并且该系列化合物对于植物病原真菌如葡萄座腔病菌、水稻纹枯病菌、辣椒枯萎病菌、茄子黄萎病菌、小麦赤霉病菌、油菜菌核病菌等具有优异的防治效果。The invention uses tryptamine or tryptamine derivatives as starting materials, uses aldehydes or ketones of different structures as connecting chains, introduces a series of alkyl groups or amino groups into the system, and synthesizes a series of 1,2,3,4-tetrahydro-β-carboline compounds. The compounds have excellent inhibitory effects on plant pathogenic bacteria such as rice bacterial blight, citrus canker, kiwi fruit canker, etc.; and the series of compounds have excellent control effects on plant pathogenic fungi such as grape spores, rice sheath blight, pepper wilt, eggplant verticillium dahliae, wheat fusarium head blight, rapeseed sclerotinia, etc.
具体实施方式DETAILED DESCRIPTION
下面将结合本发明实施例中的技术方案进行清楚、完整地描述,显然,所举实施例是为了更好地对本发明进行说明,但并不是本发明的内容仅局限于所举实施例。所以熟悉本领域的技术人员根据上述发明内容对实施方案进行非本质的改进和调整,仍属于本发明的保护范围。The following will be described clearly and completely in conjunction with the technical solutions in the embodiments of the present invention. Obviously, the embodiments are for better illustrating the present invention, but the content of the present invention is not limited to the embodiments. Therefore, those skilled in the art can make non-essential improvements and adjustments to the implementation scheme according to the above invention content, which still fall within the protection scope of the present invention.
本文中使用的术语仅用于描述特定实施例,并且无意于限制本公开。除非在上下文中具有明显不同的含义,否则单数形式的表达包括复数形式的表达。如本文所使用的,应当理解,诸如“包括”、“具有”、“包含”之类的术语旨在指示特征、数字、操作、组件、零件、元件、材料或组合的存在。在说明书中公开了本发明的术语,并且不旨在排除可能存在或可以添加一个或多个其他特征、数字、操作、组件、部件、元件、材料或其组合的可能性。如在此使用的,根据情况,“/”可以被解释为“和”或“或”。The terms used herein are only used to describe specific embodiments and are not intended to limit the present disclosure. Unless the context has a significantly different meaning, expressions in the singular include expressions in the plural. As used herein, it should be understood that terms such as "include", "have", "comprise" and the like are intended to indicate the presence of features, numbers, operations, components, parts, elements, materials or combinations. The terms of the present invention are disclosed in the specification, and are not intended to exclude the possibility that one or more other features, numbers, operations, components, parts, elements, materials or combinations thereof may exist or may be added. As used herein, "/" may be interpreted as "and" or "or", depending on the circumstances.
本发明中所使用到的术语“烷基”是包括具有特定数目碳原子的支链和直链饱和烃基。例如“C1-10烷基”(或亚烷基)目的是C1、C2、C3、C4、C5、C6、C7、C8、C9和C10烷基。另外,例如“C1-6烷基”表示具有1到6个碳原子的烷基。烷基可为非取代或取代的,以使一个或多个其氢原子被其它化学基团取代。烷基的实施例包括但不限于甲基(Me)、乙基(Et)、丙基(如正丙基和异丙基)、丁基(如正丁基、异丁基、叔丁基)、戊基(如正戊基、异戊基、新戊基)及其类似物。The term "alkyl" as used in the present invention includes branched and straight chain saturated hydrocarbon groups having a specific number of carbon atoms. For example, "C 1-10 alkyl" (or alkylene) refers to C1, C2, C3, C4, C5, C6, C7, C8, C9 and C10 alkyl. In addition, for example, "C 1-6 alkyl" refers to an alkyl group having 1 to 6 carbon atoms. The alkyl group may be unsubstituted or substituted so that one or more of its hydrogen atoms are replaced by other chemical groups. Examples of alkyl groups include, but are not limited to, methyl (Me), ethyl (Et), propyl (such as n-propyl and isopropyl), butyl (such as n-butyl, isobutyl, tert-butyl), pentyl (such as n-pentyl, isopentyl, neopentyl) and the like.
本发明中所使用到的术语“烯基”是既包括直链或支链结构的烃,且具有一个或多个出现在链中任何稳定点的碳-碳双键。例如“C2-6烯基”(或亚烯基)目的是包括C2、C3、C4、C5和C6烯基。烯基的实例包括但不限于乙烯基、1-丙烯基,2-丙烯基、2-丁烯基、3-丁烯基、2-戊烯基、3-戊烯基、4-戊烯基、2-己烯基、3-己烯基、4-己烯基、5-己烯基、2-甲基-2-丙烯基、4-甲基-3-戊烯基及其类似物。The term "alkenyl" as used in the present invention is a hydrocarbon that includes both straight or branched structures and has one or more carbon-carbon double bonds that appear at any stable point in the chain. For example, " C2-6 alkenyl" (or alkenylene) is intended to include C2, C3, C4, C5 and C6 alkenyl. Examples of alkenyl include, but are not limited to, vinyl, 1-propenyl, 2-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-methyl-2-propenyl, 4-methyl-3-pentenyl and the like.
本发明中用到的术语“取代的”指的是在指定原子或基团上的任意一个或多个氢原子以选择的指定基团取代,前提是不超过指定原子的一般化合价。如果没有其它说明,取代基命名至中心结构。例如,可以理解的是当(环烷基)烷基是可能的取代基,该取代基至中心结构的连接点是在烷基部分中。此处使用的环双键是形成于两个临近环原子之间的双键(如C=C、C=N或N=N)。当提到取代时,特别是多取代时,指的是多个取代基在指定基团上的各个位置上取代,如二氯苄基指的是2,3-二氯苄基、2,4-二氯苄基、2,5-二氯苄基、2,6-二氯苄基、3,4-二氯苄基和3,5-二氯苄基。The term "substituted" as used herein refers to the replacement of any one or more hydrogen atoms on a designated atom or group with a selected designated group, provided that the general valence of the designated atom is not exceeded. If not otherwise specified, the substituents are named to the central structure. For example, it is understood that when (cycloalkyl) alkyl is a possible substituent, the point of attachment of the substituent to the central structure is in the alkyl portion. A ring double bond as used herein is a double bond formed between two adjacent ring atoms (such as C=C, C=N or N=N). When referring to substitution, especially polysubstitution, it means that multiple substituents are substituted at various positions on the designated group, such as dichlorobenzyl refers to 2,3-dichlorobenzyl, 2,4-dichlorobenzyl, 2,5-dichlorobenzyl, 2,6-dichlorobenzyl, 3,4-dichlorobenzyl and 3,5-dichlorobenzyl.
取代基和变量的组合是允许的,仅当这些组合产生稳定的化合物或有用的合成中间体。稳定的化合物或稳定结构暗示所述化合物以有用的纯度从反应混合物分离出来时是足够稳定的,随之配制形成有效的治疗试剂。Combinations of substituents and variables are permissible only if such combinations result in stable compounds or useful synthetic intermediates. A stable compound or stable structure implies that the compound is sufficiently stable to be isolated in a useful degree of purity from a reaction mixture, and then formulated into an efficacious therapeutic agent.
术语“杂芳基”指的是取代和非取代芳香5或6元单环基团,9-或10-元双环基团,和11到14元三环基团,在至少一个环中具有至少一个杂原子(O,S或N),所述含杂原子的环优选具有1、2或3个选自O、S和N中的杂原子。含杂原子的杂芳基的每个环可含一个或两个氧或硫原子和/或由1到4个氮原子,前提是每个环中杂原子的总数是4或更少,且每个环具有至少一个碳原子。完成双环和三环基团的稠合环可仅含有碳原子,并可以是饱和、部分饱和或不饱和。氮可任选被氧化及被季铵化。双环或三环的杂芳基必须包括至少一个全芳香环,氮其它稠合环可为芳香性或非芳香性的。杂芳基可在任何环的任何可利用氮或碳原子上连接。当化合价允许,如果所述其它环是环烷基或杂环,其另外任选以=O(氧)取代。The term "heteroaryl" refers to substituted and unsubstituted aromatic 5 or 6-membered monocyclic groups, 9- or 10-membered bicyclic groups, and 11 to 14-membered tricyclic groups, having at least one heteroatom (O, S or N) in at least one ring, the heteroatom-containing ring preferably having 1, 2 or 3 heteroatoms selected from O, S and N. Each ring of the heteroatom-containing heteroaryl group may contain one or two oxygen or sulfur atoms and/or from 1 to 4 nitrogen atoms, provided that the total number of heteroatoms in each ring is 4 or less and each ring has at least one carbon atom. The fused rings completing the bicyclic and tricyclic groups may contain only carbon atoms and may be saturated, partially saturated or unsaturated. The nitrogen may be optionally oxidized and quaternized. The bicyclic or tricyclic heteroaryl group must include at least one fully aromatic ring, and the nitrogen other fused rings may be aromatic or non-aromatic. The heteroaryl group may be attached at any available nitrogen or carbon atom of any ring. If the other ring is a cycloalkyl or heterocycle, it is additionally optionally substituted with =0 (oxygen) when valence permits.
示例性单环杂芳基包括吡咯基、吡唑基、吡唑啉基、咪唑基、噁唑基、异噁唑基、噻唑基、噻二唑基、呋喃基、噻吩基、噁二唑基、吡啶基、吡嗪基、嘧啶基、哒嗪基、三嗪基及其类似物。Exemplary monocyclic heteroaryl groups include pyrrolyl, pyrazolyl, pyrazolinyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, furanyl, thienyl, oxadiazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, and the like.
示例性双环杂芳基包括吲哚基、苯并噻唑基、苯并二氧杂环戊烯基、苯并噁唑基、苯并噻吩基、喹啉基、四氢异喹啉基、异喹啉基、苯并咪唑基、苯并呋喃基、吲哚嗪基、苯并呋喃基、色酮基、香豆素基、苯并呋喃基、噌啉基、喹喔啉基、吲唑基、吡咯并吡啶基、氟代吡啶基、二氢异吲哚基、四氢喹啉基及其类似物。Exemplary bicyclic heteroaryl groups include indolyl, benzothiazolyl, benzodioxolyl, benzoxazolyl, benzothiophenyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, benzofuranyl, indolizinyl, benzofuranyl, chromonyl, coumarinyl, benzofuranyl, cinnolinyl, quinoxalinyl, indazolyl, pyrrolopyridinyl, fluoropyridinyl, dihydroisoindolyl, tetrahydroquinolinyl, and the like.
本发明中所使用到的术语“化合物”如果没有其它说明,理解为包括游离态和其盐。“盐”表示以无机和/或有机酸和碱形成酸式和/或碱式盐;另外,盐可包括两性离子(内盐),如当式I化合物含有碱性片段如胺或吡啶或咪唑环,和酸式片段如羧酸。药物上可接受的(即非毒性、生理学上可接受的)盐是优选的,如可接受的金属和胺盐,其中阳离子没有显著贡献毒性或盐的生物活性。然而,其它盐可是有用的,如在制备过程中采用分离或纯化步骤,因此也包含于本发明范围中。The term "compound" used in the present invention is understood to include the free state and its salts if there is no other explanation. "Salt" means acidic and/or basic salts formed with inorganic and/or organic acids and bases; in addition, salts may include zwitterions (inner salts), such as when the compound of formula I contains basic fragments such as amines or pyridine or imidazole rings, and acidic fragments such as carboxylic acids. Pharmaceutically acceptable (i.e., non-toxic, physiologically acceptable) salts are preferred, such as acceptable metal and amine salts, in which the cation does not significantly contribute to the toxicity or biological activity of the salt. However, other salts may be useful, such as separation or purification steps used in the preparation process, and are therefore also included in the scope of the present invention.
本发明中,C1-C8烷基指的是甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基及其同分异构体;C2-C6烯基指的是乙烯基、丙烯基、烯丙基、丁烯基、戊烯基、己烯基及其同分异构体。In the present invention, C 1 -C 8 alkyl refers to methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl and isomers thereof; C 2 -C 6 alkenyl refers to vinyl, propenyl, allyl, butenyl, pentenyl, hexenyl and isomers thereof.
当提到取代基为烯基、烷基、芳基、苄基、环烷基时,或这些取代基具体的为某个具体的烯基、烷基、芳基、苄基、环烷基时,指的是一个到三个上述取代基。如氯苄基指的是一个到三个氯取代的苄基。When a substituent is referred to as alkenyl, alkyl, aryl, benzyl, or cycloalkyl, or when these substituents are specifically alkenyl, alkyl, aryl, benzyl, or cycloalkyl, it refers to one to three of the above substituents. For example, chlorobenzyl refers to one to three chlorine-substituted benzyls.
本申请以色胺或色胺衍生物为起始原料,合成一系列含不同取代基的1,2,3,4-四氢-β-咔啉类化合物,其结构式如下所示:The present invention uses tryptamine or tryptamine derivatives as starting materials to synthesize a series of 1,2,3,4-tetrahydro-β-carboline compounds containing different substituents, and the structural formula thereof is shown below:
式中,R1和R2各自独立的选自氢、任意取代或未取代的烷基、任意取代或未取代的烯基、任意取代或未取代的环烷基、任意取代或未取代的芳基、任意取代或未取代的杂芳基中的一个或多个、任意取代或未取代的苄基、任意取代或未取代的α-甲基-苄基;In the formula, R1 and R2 are each independently selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl, optionally substituted or unsubstituted benzyl, and optionally substituted or unsubstituted α-methyl-benzyl;
或R1和R2相连构成任意取代的4-10元环或含杂原子的环,所述杂原子为N、O和S中的至少一个;or R1 and R2 are linked to form an optionally substituted 4-10 membered ring or a ring containing a heteroatom, wherein the heteroatom is at least one of N, O and S;
R3选自氢、任意取代或未取代的烷基、任意取代或未取代的烯基、任意取代或未取代的环烷基、任意取代或未取代的芳基、任意取代或未取代的杂芳基中的一个或多个、任意取代或未取代的苄基、任意取代或未取代的α-甲基-苄基;R3 is selected from one or more of hydrogen, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl, optionally substituted or unsubstituted benzyl, optionally substituted or unsubstituted α-methyl-benzyl;
在一些实施方式中,所述R1和R2各自独立的选自氢、任意取代或未取代的C1-8烷基、任意取代或未取代的C2-6烯基、任意取代或未取代的C5-10环烷基、任意取代或未取代的C5-10芳基、任意取代或未取代的C5-10杂芳基、任意取代或未取代的苄基;In some embodiments, R1 and R2 are each independently selected from hydrogen, optionally substituted or unsubstituted C1-8 alkyl, optionally substituted or unsubstituted C2-6 alkenyl, optionally substituted or unsubstituted C5-10 cycloalkyl, optionally substituted or unsubstituted C5-10 aryl, optionally substituted or unsubstituted C5-10 heteroaryl, and optionally substituted or unsubstituted benzyl;
或R1和R2相连构成任意取代的5-10元环或含杂原子的环,所述杂原子为N、O和S中的至少一个;or R1 and R2 are linked to form an optionally substituted 5-10 membered ring or a ring containing a heteroatom, wherein the heteroatom is at least one of N, O and S;
R3选自氢、任意取代或未取代的C1-8烷基、任意取代或未取代的C2-6烯基、任意取代或未取代的C5-10环烷基、任意取代或未取代的C5-10芳基、任意取代或未取代的C5-10杂芳基、任意取代或未取代的苄基;R3 is selected from hydrogen, optionally substituted or unsubstituted C1-8 alkyl, optionally substituted or unsubstituted C2-6 alkenyl, optionally substituted or unsubstituted C5-10 cycloalkyl, optionally substituted or unsubstituted C5-10 aryl, optionally substituted or unsubstituted C5-10 heteroaryl, optionally substituted or unsubstituted benzyl;
在一些实施方案中,所述R1、R2和R3各自独立的选氢、氘、甲基、乙基、正丙基、异丙基、苯基、正丁基、异丁基、仲丁基、叔丁基、正戊基、异戊基、新戊基、己基、庚基、辛基、1,1-二甲基、1,5-二甲基己基、1,1-二乙醇基、丙烯基、烯丙基、甲氧基、乙氧基、丙氧基、丁氧基、苯基、4-硝基苯基、4-乙氧基苯基、4-氨基苯基、2,4-二氟苯基、2-氯-4-氟苯基、2-甲基-4氟苯基、2,5-二氯苯基、2,4-二氯苯基、2-氯-4溴苯基、2-甲基-4氯苯基、4-甲基-3-氯苯基、苄基、2-氟苄基、4-氟苄基、4-三氟甲基苄基、2-氯苄基、3-氯苄基、4-氯苄基、4-甲基苄基、4-甲氧基苄基、苯乙基、环丙基、环戊基、呋喃甲基、噻吩甲基,α-甲基苄基、氟-α-甲基苄基、甲氧基-α-甲基苄基;In some embodiments, R1, R2 and R3 are each independently selected from hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, phenyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, 1,1-dimethyl, 1,5-dimethylhexyl, 1,1-diethanol, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, phenyl, 4-nitrophenyl, 4-ethoxyphenyl, 4-aminophenyl, 2,4-difluorophenyl, 2-chlorophenyl, -4-fluorophenyl, 2-methyl-4-fluorophenyl, 2,5-dichlorophenyl, 2,4-dichlorophenyl, 2-chloro-4-bromophenyl, 2-methyl-4-chlorophenyl, 4-methyl-3-chlorophenyl, benzyl, 2-fluorobenzyl, 4-fluorobenzyl, 4-trifluoromethylbenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 4-methylbenzyl, 4-methoxybenzyl, phenethyl, cyclopropyl, cyclopentyl, furanyl, thephenylmethyl, α-methylbenzyl, fluoro-α-methylbenzyl, methoxy-α-methylbenzyl;
在一些实施方式中,本发明提供的含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物选自以下结构中的任一种:In some embodiments, the alkyl or aryl-containing 1,2,3,4-tetrahydro-β-carboline compound provided by the present invention is selected from any one of the following structures:
本发明还提供了上述技术方案所述含烷基或芳基的1,2,3,4-四氢-β-咔啉类化合物的制备方法,以色胺或色胺衍生物为起始原料,以三氟乙酸(TFA)为催化剂,与酮或醛在溶剂中60℃加热搅拌反应6h~8h。反应通式为:The present invention also provides a method for preparing 1,2,3,4-tetrahydro-β-carboline compounds containing alkyl or aromatic groups as described in the above technical scheme, using tryptamine or a tryptamine derivative as a starting material, trifluoroacetic acid (TFA) as a catalyst, and reacting with a ketone or an aldehyde in a solvent at 60° C. under heating and stirring for 6 h to 8 h. The general reaction formula is:
在一些实施方式中,所述酮与色胺或色胺衍生物的摩尔比为1.2:1;所述醛与色胺或色胺衍生物的摩尔比为1.2:1。In some embodiments, the molar ratio of the ketone to tryptamine or a tryptamine derivative is 1.2:1; the molar ratio of the aldehyde to tryptamine or a tryptamine derivative is 1.2:1.
在一些实施方式中,所述溶剂为二氯甲烷(DCM)。In some embodiments, the solvent is dichloromethane (DCM).
在本发明中,所述反应的具体操作为:将色胺或色胺衍生物和不同种类的醛或酮加入到二氯甲烷中,再慢慢滴加三氟乙酸,60℃进行反应,反应结束后,用水淬灭反应体系,用乙酸乙酯萃取有机物,10%的碳酸钾溶液进行洗涤,无水硫酸钠干燥,除去溶剂,纯化分离后得到目标化合物。In the present invention, the specific operation of the reaction is: adding tryptamine or a tryptamine derivative and different types of aldehydes or ketones to dichloromethane, then slowly adding trifluoroacetic acid, reacting at 60°C, quenching the reaction system with water after the reaction, extracting organic matter with ethyl acetate, washing with 10% potassium carbonate solution, drying with anhydrous sodium sulfate, removing the solvent, and purifying and separating to obtain the target compound.
本发明还提供了含有所述化合物的组合物。The present invention also provides a composition containing the compound.
在一些实施方式中,所述组合物的剂型为乳油、可湿性粉剂、颗粒剂、水剂、悬浮剂、超低容量喷雾剂、可溶性粉剂、微胶囊剂、烟剂、水乳剂或水分散性粒剂;所述组合物可以是上述化合物与农业上的助剂制成杀菌剂、杀虫剂或除草剂。In some embodiments, the composition is in the form of emulsifiable concentrate, wettable powder, granules, aqueous solution, suspension, ultra-low volume spray, soluble powder, microcapsule, smoke agent, aqueous emulsion or water-dispersible granules; the composition can be a fungicide, insecticide or herbicide prepared by combining the above-mentioned compounds with agricultural adjuvants.
本发明还提供了所述化合物或所述组合物在防治农业病虫害中的应用。The invention also provides application of the compound or the composition in preventing and controlling agricultural pests and diseases.
在一些实施方式中,所述农业病虫害为植物细菌性病害或植物真菌性病害,具体的,所述农业病虫害为植物叶枯病或植物溃疡病。In some embodiments, the agricultural pests and diseases are plant bacterial diseases or plant fungal diseases. Specifically, the agricultural pests and diseases are plant leaf blight or plant canker.
进一步的,所述细菌性病害为水稻白叶枯病、黄瓜白叶枯病、魔芋白叶枯病、柑橘溃疡病、烟草青枯病、葡萄溃疡病、番茄溃疡病、猕猴桃溃疡病、苹果溃疡病。Furthermore, the bacterial diseases are rice bacterial leaf blight, cucumber bacterial leaf blight, konjac bacterial leaf blight, citrus canker, tobacco bacterial wilt, grape canker, tomato canker, kiwi fruit canker, and apple canker.
进一步的,所述真菌性病害为黄瓜灰霉病、辣椒枯萎病、油菜菌核病、小麦赤霉病、马铃薯晚疫病、蓝莓根腐病、葡萄座腔菌、火龙果炭疽病、水稻纹枯病、茄子黄萎病。Furthermore, the fungal diseases are cucumber gray mold, pepper wilt, rapeseed sclerotinia, wheat fusarium wilt, potato late blight, blueberry root rot, grape syringa, pitaya anthracnose, rice sheath blight, and eggplant verticillium wilt.
本发明还提供了一种防治农业病虫害的方法:将所述化合物或所述组合物作用于有害物或其生活的环境,或直接将组合物与植物接触。The present invention also provides a method for preventing and controlling agricultural pests and diseases: the compound or the composition is applied to harmful substances or their living environment, or the composition is directly contacted with plants.
为了更好地理解本发明,下面结合实施例进一步阐明本发明的内容,但本发明的内容不仅仅局限于下面的实施例。实施例中用到的所有原料和溶剂均为市售产品。In order to better understand the present invention, the content of the present invention is further explained in conjunction with the following examples, but the content of the present invention is not limited to the following examples. All raw materials and solvents used in the examples are commercially available products.
实施例1Example 1
1-(4-(三氟甲氧基)苯基)-2,3,4,9-四氢-1H-吡啶[3,4-b]吲哚的制备Preparation of 1-(4-(trifluoromethoxy)phenyl)-2,3,4,9-tetrahydro-1H-pyridin[3,4-b]indole
将色胺(0.5g,0.2mmol),TFA(227L,3mmol)及6mL二氯甲烷加入到25mL圆底烧瓶中,常温下搅拌20min,然后加入4-三氟甲氧基苯甲醛(0.4g,2.4mmol),60℃加热搅拌8h后结束反应,用水淬灭反应,乙酸乙酯萃取收集有机相,并用10%的K2CO3溶液洗涤,无水硫酸钠干燥,脱溶,柱层析(CH2Cl2:CH3OH=10:1,v/v),得黄色固体,收率92.8%。Tryptamine (0.5 g, 0.2 mmol), TFA (227 L, 3 mmol) and 6 mL of dichloromethane were added to a 25 mL round-bottom flask, stirred at room temperature for 20 min, then 4-trifluoromethoxybenzaldehyde (0.4 g, 2.4 mmol) was added, and the reaction was terminated after heating and stirring at 60°C for 8 h. The reaction was quenched with water, and the organic phase was collected by extraction with ethyl acetate, washed with 10% K2CO3 solution , dried over anhydrous sodium sulfate, desolventized, and subjected to column chromatography ( CH2Cl2 : CH3OH =10:1, v/v) to obtain a yellow solid with a yield of 92.8 % .
其核磁数据为:1H NMR(500MHz,CDCl3)δ8.09(s,1H,NH),7.60–7.55(m,1H,ph-H),7.26(d,J=8.6Hz,2H,ph-H),7.19(s,1H,ph-H),7.17(s,1H,ph-H),7.15(s,1H,ph-H),7.14(d,J=2.3Hz,2H,ph-H),5.08(s,1H,CH),3.26(d,J=12.5Hz,1H,CH2),3.09(s,1H,CH2),2.84(d,J=1.4Hz,2H,CH2),1.97(s,1H,NH).13C NMR(126MHz,CDCl3)δ149.08,140.71,136.09,133.71,130.14,127.34,122.04,121.38,119.60,118.45,111.05,110.55,57.22,42.45,22.49.Its NMR data are: 1 H NMR (500MHz, CDCl 3 )δ8.09(s,1H,NH),7.60–7.55(m,1H,ph-H),7.26(d,J=8.6Hz,2H,ph-H),7.19(s,1H,ph-H),7.17(s,1H,ph-H),7.15(s,1H,ph-H),7.14(d,J=2.3Hz,2H,ph-H),5.08(s,1H,CH),3.26(d,J=12.5Hz,1H,CH 2 ),3.09(s,1H,CH 2 ),2.84(d,J=1.4Hz,2H,CH 2 ),1.97(s,1H,NH). 13 C NMR (126MHz,CDCl 3 )δ149.08,140.71,136.09,133.71,130.14,127.34,122.04,121.38,119.60,118.45,111.05,110.55,57.22,42.45,22.49.
实施例2Example 2
6-甲氧基-1-(4-(三氟甲氧基)苯基)-2,3,4,9-四氢-1H-吡啶[3,4-b]吲哚的制备Preparation of 6-methoxy-1-(4-(trifluoromethoxy)phenyl)-2,3,4,9-tetrahydro-1H-pyridin[3,4-b]indole
将5-甲氧基色胺(0.15g,0.8mmol)和对三氟甲氧基苯甲醛(139μL,0.96mmol)加入到含有6mL二氯甲烷的15mL耐压管中,加入三氟乙酸(94μL,1.2mmol),60℃加热搅拌,TLC检测反应直至反应完全,用水淬灭反应,乙酸乙酯萃取收集有机相,并用10%的K2CO3溶液洗涤,无水硫酸钠干燥,并在真空下除去溶剂,通过使用二氯甲烷:甲醇=10:1作为洗脱剂纯化产物,得到黄色固体,产率56.3%。5-Methoxytryptamine (0.15 g, 0.8 mmol) and p-trifluoromethoxybenzaldehyde (139 μL, 0.96 mmol) were added to a 15 mL pressure tube containing 6 mL of dichloromethane, and trifluoroacetic acid (94 μL, 1.2 mmol) was added. The mixture was heated and stirred at 60°C. The reaction was detected by TLC until the reaction was complete. The reaction was quenched with water, and the organic phase was collected by extraction with ethyl acetate and washed with 10% K 2 CO 3 solution, dried over anhydrous sodium sulfate, and the solvent was removed under vacuum. The product was purified by using dichloromethane: methanol = 10: 1 as the eluent to obtain a yellow solid with a yield of 56.3%.
其核磁数据为:1H NMR(400MHz,CDCl3)δ7.85(s,1H,NH),7.31(d,J=8.6Hz,2H,Ar-H),7.20(d,J=8.1Hz,2H,Ar-H),7.08(s,1H,Ar-H),7.04(d,J=2.4Hz,1H,Ar-H),6.83(d,J=2.4Hz,1H,Ar-H),5.13(s,1H,CH),3.89(s,3H,CH3),3.30(s,1H,CH2),3.13(s,1H,CH2),2.82(d,J=0.9Hz,2H,CH2),1.91(s,1H,NH).13C NMR(101MHz,CDCl3)δ154.05,148.97,148.95(q,3JC-F=2.4Hz),140.68,134.64,131.03,129.99,127.64,121.30(q,1JC-F=258.3Hz),111.75,111.64,110.29,100.47,57.29,55.95,42.52,22.51.Its nuclear magnetic data are: 1 H NMR (400MHz, CDCl 3 ) δ7.85 (s, 1H, NH), 7.31 (d, J = 8.6Hz, 2H, Ar-H), 7.20 (d, J = 8.1Hz, 2H, Ar-H), 7.08 (s, 1H, Ar-H), 7.04 (d, J=2.4Hz, 1H, Ar-H), 6.83 (d, J=2.4Hz, 1H, Ar-H), 5.13(s,1H,CH),3.89(s,3H,CH 3 ),3.30(s,1H,CH2),3.13(s,1H,CH 2 ),2.82(d,J=0.9Hz,2H,CH 2 ),1.91(s,1H,NH). 13 C NMR(101MHz, CDCl 3 )δ154.05,148.97,148.95(q, 3 J CF =2.4Hz),140.68,134.64,131.03,129.99,127.64,121.30(q, 1 J CF =258.3Hz),111.75,111.64,110.29,100.4 7,57.29,55.95 ,42.52,22.51.
以上述实施例类似的步骤,仅替换相应的原料制备得到下述化合物。所述化合物的结构及核磁共振氢谱和碳谱数据如表1所示,物化性质如表2所示。The following compounds were prepared by similar steps to the above examples except that the corresponding raw materials were replaced. The structures and H NMR and C NMR data of the compounds are shown in Table 1, and the physicochemical properties are shown in Table 2.
表1化合物的核磁共振氢谱和碳谱数据Table 1 H NMR and C NMR data of compounds
表2目标化合物的理化性质Table 2 Physicochemical properties of target compounds
试验例1Test Example 1
EC50(median effective concentration)是评价植物病原菌对化合物敏感性的重要指标,同时也是对目标化合物作用机制研究时,化合物浓度设置的重要参数。在浓度梯度实验中,采用二倍稀释法设定合适的5个浓度,最后将药剂对植物病原菌的抑制率、药剂浓度换算成对数值,通过SPSS软件回归分析得到毒力曲线,计算出EC50。EC 50 (median effective concentration) is an important indicator for evaluating the sensitivity of plant pathogens to compounds. It is also an important parameter for setting compound concentration when studying the mechanism of action of target compounds. In the concentration gradient experiment, the two-fold dilution method was used to set 5 appropriate concentrations. Finally, the inhibition rate of the agent on plant pathogens and the concentration of the agent were converted into logarithmic values. The toxicity curve was obtained through regression analysis with SPSS software, and EC 50 was calculated.
采用浊度法测试目标化合物对植物病原菌的有效中浓度EC50,试验对象为水稻白叶枯病菌(Xoo)、柑橘溃疡病菌(Xac)和猕猴桃溃疡病菌(Psa)。DMSO溶解在NB培养基中作为空白对照。将水稻白叶枯病菌(在M210固体培养基)放到NB培养基中,在28℃、180rpm恒温摇床中振荡培养到对数生长期备用;将柑橘溃疡病菌(在M210固体培养基上)放到NB培养基中;将水稻细菌性条斑病菌(在M210固体培养基上)放到NB培养基中,在28℃、180rpm恒温摇床中振荡培养到对数生长期备用。将药剂(化合物)配置成不同浓度(例:100,50,25,12.5,6.25μg/mL)的含毒NB液体培养基5mL加入到试管中,分别加入40μL含有植病细菌的NB液体培养基,在28~30℃、180rpm恒温摇床中振荡,其中水稻白叶枯病原菌培养48h,柑橘溃疡病菌培养48h,水稻细菌性条斑病菌培养36h。将各个浓度的菌液在酶标仪上测定OD595值,并且另外测定对应浓度的含毒无菌NB液体培养基的OD595值。The effective medium concentration EC 50 of the target compound against plant pathogens was tested by turbidity method. The test objects were Xanthoceras oryzae (Xoo), Xanthoceras citri citri (Xac) and Xanthoceras kiwifruit (Psa). DMSO was dissolved in NB medium as a blank control. Xanthoceras oryzae (on M210 solid medium) was placed in NB medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase for use; Xanthoceras citri citri (on M210 solid medium) was placed in NB medium; Xanthoceras oryzae (on M210 solid medium) was placed in NB medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase for use. 5 mL of toxic NB liquid culture medium containing different concentrations (e.g., 100, 50, 25, 12.5, 6.25 μg/mL) of the agent (compound) was added to a test tube, and 40 μL of NB liquid culture medium containing plant pathogenic bacteria was added respectively, and the mixture was shaken in a constant temperature shaker at 28-30°C and 180 rpm, wherein the rice bacterial leaf blight pathogen was cultured for 48 hours, the citrus canker pathogen was cultured for 48 hours, and the rice bacterial leaf streak pathogen was cultured for 36 hours. The OD 595 value of the bacterial solution of each concentration was measured on an ELISA instrument, and the OD 595 value of the toxic sterile NB liquid culture medium of the corresponding concentration was also measured.
其中,NB培养基:水:1L,葡萄糖:10g,蛋白栋:5g,牛肉膏:3g,酵母粉:1g,M210固体培养基:水:1L,葡萄糖:10g,蛋白栋:5g,牛肉膏:3g,酵母粉:1g,琼脂:15g。Among them, NB medium: water: 1L, glucose: 10g, protein: 5g, beef extract: 3g, yeast powder: 1g, M210 solid medium: water: 1L, glucose: 10g, protein: 5g, beef extract: 3g, yeast powder: 1g, agar: 15g.
校正OD值=含菌培养基OD值-无菌培养基OD值Corrected OD value = OD value of bacterial culture medium - OD value of sterile culture medium
抑制率%=[(校正后对照培养基菌液OD值-校正含毒培养基OD值)/校正后对照培养基菌液OD值]×100Inhibition rate % = [(corrected control culture medium bacterial solution OD value - corrected toxic culture medium OD value) / corrected control culture medium bacterial solution OD value] × 100
本发明实施例辅以说明本发明的技术方案,但实施例的内容并不局限于此,目标化合物实验结果如表3所示。The examples of the present invention are used to illustrate the technical solutions of the present invention, but the contents of the examples are not limited thereto. The experimental results of the target compounds are shown in Table 3.
表3含烷基或芳基取代的1,2,3,4-四氢-β-咔啉类化合物对植物病原细菌的EC50 Table 3 EC 50 of 1,2,3,4-tetrahydro-β-carboline compounds containing alkyl or aryl substitution against plant pathogenic bacteria
从表3中可以看出,在离体试验中,部分目标化合物对植物致病病原菌(如水稻白叶枯病菌、柑橘溃疡病菌和猕猴桃溃疡病菌)表现出了良好的抑制活性。化合物17对水稻白叶枯病菌、柑橘溃疡病菌具有极好的抑制活性,其EC50分别为7.27、4.89g mL-1;化合物8对猕猴桃溃疡病菌具有极好的抑制活性,其EC50为4.87g mL-1,可用于制备抗植物致病病原细菌农药。As can be seen from Table 3, in the in vitro test, some target compounds showed good inhibitory activity against plant pathogenic bacteria (such as Xanthoceras oryzae, Xanthoceras citri citrifolia and Xanthoceras kiwifruit). Compound 17 had excellent inhibitory activity against Xanthoceras oryzae and Xanthoceras citrifolia, with EC 50 values of 7.27 and 4.89 g mL -1 , respectively; Compound 8 had excellent inhibitory activity against Xanthoceras citrifolia, with EC 50 value of 4.87 g mL -1 , and can be used to prepare pesticides against plant pathogenic bacteria.
试验例2:Test Example 2:
采用生长速率法测试目标化合物(50μg/mL)对植物病原菌的抑制率,试验对象为葡萄座腔菌(B.dothidea)、水稻纹枯病菌(R.solani Kühn)、辣椒枯萎病菌(F.oxysporum)、茄子黄萎病菌(V.dahlia)、小麦赤霉病菌(G.zeae)。二甲基亚砜(DMSO)溶解在培养基中作为空白对照。用万分之一天平称取待测化合物,加入1mL DMSO溶解化合物,然后在无菌操作台中转移至15mL灭菌的离心管中,加入9mL吐温水(Tween-20)定容至10mL,倒入融化的培养基中,混匀后平均分装至9个培养皿中冷却备用;在无菌操作台内,将打孔器(5mm)灼烧灭菌,把菌落制成菌饼,用接菌环把菌饼接在培养基的中央,于25~28℃条件下培养5天左右,待空白对照的菌落生长至6cm左右用直尺按十字交叉法测量2次,取其平均值作为菌落的直径大小。根据计算公式求出每个浓度的菌丝生长抑制率。The growth rate method was used to test the inhibition rate of the target compound (50 μg/mL) on plant pathogens, and the test objects were Botrytis cinerea (B. dothidea), Rice Sheath Blight (R. solani Kühn), Pepper Wilt (F. oxysporum), Eggplant Verticillium dahlia (V. dahlia), and Wheat Gibberellic Acid (G. zeae). Dimethyl sulfoxide (DMSO) was dissolved in the culture medium as a blank control. Weigh the compound to be tested with a 1/10,000 balance, add 1 mL DMSO to dissolve the compound, then transfer it to a 15 mL sterilized centrifuge tube on a sterile operating table, add 9 mL Tween-20 to make it 10 mL, pour it into the melted culture medium, mix it evenly and evenly distribute it into 9 culture dishes for cooling and standby use; in a sterile operating table, burn and sterilize the puncher (5 mm), make the colony into a bacterial cake, use a bacterial ring to connect the bacterial cake to the center of the culture medium, and culture it at 25-28°C for about 5 days. When the blank control colony grows to about 6 cm, use a ruler to measure it twice by the cross method, and take the average value as the diameter of the colony. Calculate the mycelium growth inhibition rate of each concentration according to the calculation formula.
其中,DMSO溶解在PDA培养基中,PDA培养基为:马铃薯,琼脂粉,葡萄糖,硫酸镁,磷酸二氢钾,维生素B1,自然pH,121℃,30min灭菌。具体过程为:1000mL马铃薯煮汁:将马铃薯去皮洗净切丝后称200g于1L二次水中煮至土豆丝可用手指轻轻捻碎,纱布过滤;称取20g琼脂粉于烧杯中,加入少量冷水划散后将其倒入沸腾的马铃薯溶液中,煮至琼脂粉融化,期间需不断快速搅拌,称取20g葡萄糖,硫酸镁1.5g,磷酸二氢钾3.0g、维生素B1 10mg,加至滤液中,搅拌溶解,加二次水定容至1L,自然pH,趁热量取90mL分装至200mL的锥形瓶中,用半透滤膜密封于121℃高压灭菌锅中灭菌30min备用。Among them, DMSO is dissolved in PDA medium, and PDA medium is: potato, agar powder, glucose, magnesium sulfate, potassium dihydrogen phosphate, vitamin B1, natural pH, 121℃, and sterilization for 30 minutes. The specific process is: 1000mL potato boiled juice: peel the potato, wash and cut into strips, weigh 200g, and boil it in 1L secondary water until the potato strips can be gently crushed with fingers, and filter with gauze; weigh 20g agar powder in a beaker, add a small amount of cold water to disperse it, and then pour it into the boiling potato solution, and boil until the agar powder melts. During this period, it is necessary to stir quickly and continuously. Weigh 20g glucose, 1.5g magnesium sulfate, 3.0g potassium dihydrogen phosphate, and 10mg vitamin B1, add them to the filtrate, stir to dissolve, add secondary water to make up to 1L, natural pH, take 90mL while it is hot and divide it into 200mL conical flasks, seal it with a semi-permeable filter membrane, and sterilize it in a high-pressure sterilizer at 121℃ for 30 minutes for use.
抑制率(%)=(N1-N2)/(N1-0.5)×100Inhibition rate (%) = (N1-N2)/(N1-0.5)×100
0.5—为母菌菌饼的直径/cm;0.5—is the diameter of the mother fungus cake/cm;
N1—对照菌落直径即对照组的菌落直径/cm;N1—control colony diameter, i.e., the colony diameter of the control group/cm;
N2—处理菌落直径即加目标化合物处理的菌落直径/cm:N2—treated colony diameter, i.e., colony diameter treated with target compound/cm:
本发明实施例辅以说明本发明的技术方案,但实施例的内容并不局限于此,目标化合物实验结果如表4所示。The examples of the present invention are used to illustrate the technical solutions of the present invention, but the contents of the examples are not limited thereto. The experimental results of the target compounds are shown in Table 4.
表4含烷基或芳基取代的1,2,3,4-四氢-β-咔啉类化合物对植物病原真菌的抑制活性Table 4 Inhibitory activity of 1,2,3,4-tetrahydro-β-carboline compounds containing alkyl or aryl substitutions against plant pathogenic fungi
从表4可以看出,选用5种致病病原真菌为供试对象,采用生长速率法对部分化合物进行了生物活性测试,测试结果表明,该系列化合物具有一般的抗真菌活性,其中化合物8对水稻纹枯病菌(R.solani Kühn)表现出了极好的抑制活性;化合物18对茄子黄萎病菌(V.dahlia)也表现出了极好的抑制活性。可见本发明的化合物可用于制备抗植物致病病原真菌农药。As can be seen from Table 4, 5 pathogenic fungi were selected as test objects, and the biological activity of some compounds was tested by the growth rate method. The test results showed that the series of compounds had general antifungal activity, among which compound 8 showed excellent inhibitory activity against rice sheath blight (R. solani Kühn); compound 18 also showed excellent inhibitory activity against eggplant Verticillium wilt (V. dahlia). It can be seen that the compounds of the present invention can be used to prepare pesticides against plant pathogenic fungi.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310256181.3A CN116375702B (en) | 2023-03-16 | 2023-03-16 | Alkyl or aryl-containing 1,2,3,4-tetrahydro-β-carboline compound, composition, preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310256181.3A CN116375702B (en) | 2023-03-16 | 2023-03-16 | Alkyl or aryl-containing 1,2,3,4-tetrahydro-β-carboline compound, composition, preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116375702A true CN116375702A (en) | 2023-07-04 |
CN116375702B CN116375702B (en) | 2025-06-17 |
Family
ID=86964856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310256181.3A Active CN116375702B (en) | 2023-03-16 | 2023-03-16 | Alkyl or aryl-containing 1,2,3,4-tetrahydro-β-carboline compound, composition, preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116375702B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119528904A (en) * | 2025-01-21 | 2025-02-28 | 成都大学 | Indole derivatives with antibacterial activity, preparation method thereof, use thereof, and pharmaceutical composition and medical device prepared therefrom |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102408425A (en) * | 2004-03-15 | 2012-04-11 | Ptc医疗公司 | Carboline derivatives useful in inhibition of angiogenesis and application thereof |
CN104744460A (en) * | 2013-12-30 | 2015-07-01 | 南开大学 | B-carboline, dihydro-B-carboline and tetrahydro-B-carboline alkaloid derivative as well as preparation method and application in aspects of plant virus prevention and cure, sterilization and insecticide |
JP2019151631A (en) * | 2018-03-02 | 2019-09-12 | 国立大学法人 岡山大学 | Plant disease control agent and plant disease control method |
-
2023
- 2023-03-16 CN CN202310256181.3A patent/CN116375702B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102408425A (en) * | 2004-03-15 | 2012-04-11 | Ptc医疗公司 | Carboline derivatives useful in inhibition of angiogenesis and application thereof |
CN104744460A (en) * | 2013-12-30 | 2015-07-01 | 南开大学 | B-carboline, dihydro-B-carboline and tetrahydro-B-carboline alkaloid derivative as well as preparation method and application in aspects of plant virus prevention and cure, sterilization and insecticide |
JP2019151631A (en) * | 2018-03-02 | 2019-09-12 | 国立大学法人 岡山大学 | Plant disease control agent and plant disease control method |
Non-Patent Citations (6)
Title |
---|
ACS: "STN 检索报告", 《STN REGISTRY》, 7 March 2019 (2019-03-07), pages 1 - 9 * |
HUIYING ZENG 等: "Two-in-One Strategy for Palladium-Catalyzed C-H Functionalization in Water", 《ANGEW. CHEM. INT. ED.》, vol. 58, 21 December 2018 (2018-12-21), pages 2859 - 2863 * |
KOONCHIRA BUABAN 等: "Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of Plant Pathogenic Fungi", 《MOLECULES》, vol. 26, no. 207, 3 January 2021 (2021-01-03), pages 3 * |
SHANSHAN SU 等: "Discovery and structure-activity relationship studies of novel tetrahydro-β-carboline derivatives as apoptosis initiators for treating bacterial infections", 《JOURNAL OF INTEGRATIVE AGRICULTURE》, vol. 23, no. 4, 20 May 2023 (2023-05-20), pages 1259 - 1273 * |
YEON-JU LEE 等: "Synthetic analogs of indole-containing natural products as inhibitors of sortase A and isocitrate lyase", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 20, 27 October 2010 (2010-10-27), pages 3 * |
ZHENGUO ZHANG 等: "Metal-Free Access to (Spirocyclic)Tetrahydro-β-carbolines in Water Using an Ion-Pair as a Superacidic Precatalyst", 《ACS CATAL.》, vol. 12, 24 January 2022 (2022-01-24), pages 1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119528904A (en) * | 2025-01-21 | 2025-02-28 | 成都大学 | Indole derivatives with antibacterial activity, preparation method thereof, use thereof, and pharmaceutical composition and medical device prepared therefrom |
Also Published As
Publication number | Publication date |
---|---|
CN116375702B (en) | 2025-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109627206B (en) | Preparation method and application of carbazolyl isopropanolamine derivatives with chiral centers | |
CN111454260B (en) | A class of 1,2,3,4-tetrahydro-β-carboline compounds containing isopropanolamine substructure and its preparation method and application | |
CN109627205A (en) | Preparation method and application of a class of carbazolyl isopropanolamine derivatives | |
CN110713512B (en) | Isopropanolamine substructure-containing glycyrrhetinic acid piperazine compounds and preparation method and application thereof | |
CN113636984B (en) | Morpholine group-containing 1,3, 4-oxadiazole compound and preparation method and application thereof | |
CN109535144A (en) | A kind of 1,3,4- oxadiazoles thio-ether type compounds and its preparation method and application | |
CN116375702A (en) | 1,2,3, 4-tetrahydro-beta-carboline compound containing alkyl or aryl, composition, preparation method and application | |
CN112592335A (en) | Carbazole isopropanol diamine compound containing 1, 2, 3-triazole and preparation method and application thereof | |
CN111548320A (en) | 1, 3, 4-oxadiazole hydrazide compounds and preparation method and application thereof | |
CN112624931A (en) | Pterostilbene amine compounds containing isopropanol aromatic ether structure and preparation method and application thereof | |
CN113461634B (en) | Thiazole hydrazide compound and preparation method and application thereof | |
CN110776548B (en) | Acetoxy ursolic acid piperazine compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN115260046B (en) | A kind of rosin ester compound and its preparation method and application | |
CN115850163A (en) | 3-hydroxy-2-methyl-pyridine-4 (1H) -ketone compound and preparation method and application thereof | |
CN110642916B (en) | Ursolic acid ester compounds containing tertiary amine structure and preparation method and application thereof | |
CN110078721B (en) | Triazine-containing pentadiene ketone compound and preparation method and application thereof | |
CN116082313A (en) | A compound for preventing and treating fungal diseases of plants and its preparation method | |
CN112592321B (en) | 1,2,3-triazole hydrazide or amide compounds, and preparation method and application thereof | |
CN109516978A (en) | Giantreed alkali derivant and its preparation method and application | |
CN118754840A (en) | A class of α,β-unsaturated amide or hydrazide compounds containing carbonyl structure and preparation method and application thereof | |
CN112624962A (en) | Carbazolyl isopropanolamine derivatives with double chiral centers and preparation method and application thereof | |
CN115536543B (en) | A kind of triclosan compound containing isopropanolamine structure and its preparation method and application | |
CN115521306B (en) | A kind of 1,2,3,4-tetrahydro-β-carboline derivative and its preparation method and application | |
CN116217471B (en) | A pterostilbene pyridine salt compound, intermediate compound, composition, medicine, preparation method and application | |
CN116102565B (en) | Isolamine-containing spirochromone compound and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |